Liver-on-a-chip and Tumor-on-a-chip (OOCs) End-User Survey
The client was interested in understanding the end user landscape for liver-on-a-chip and tumor-on-a-chip market in the USA and European Union (EU). As per the client’s requirements, the scope of the report included the unmet needs of the market pertaining to the following parameters: Assay throughput Specificity and reliability of the chip Price Cell type Reusability of the chip
We delivered a presentation covering: Future Prospects of Liver-on-a-chip and Tumor-on-a-chip Unmet Needs OF OOCs With Respect To- Assay Throughput Specificity, Reproducibility & Reliability Price Cell Type Reusability Characteristics Of an Ideal Liver-on-a-chip and Tumor-on-a-chip
Primary Research – The survey was carried out by conducting interviews with personnel who are the key end users of liver-on-a-chip and tumor-on-a-chip models for various experiments on a day-to-day basis. We contacted research scientists, postdoctoral fellows, bioengineers, toxicologists and pharmacologists from various companies and universities such as Takeda, AstraZeneca, GSK, Harvard University, The Institute of Cancer Research among others to gather information on assay throughput, reproducibility, current and expected pricing and other parameters.
The client was happy with the presentation and were able to understand the challenges and unmet needs of the market.